IP Protection Concerns Grow In India, PhRMA Says
This article was originally published in PharmAsia News
Executive Summary
Intellectual property protection in India is an increasing concern for industry following a year of regulatory action and inaction, according to the Pharmaceutical Research and Manufacturers of America
You may also be interested in...
Indian Generic Group Tells New Department Of Pharmaceuticals That Industry Is Under Attack By Multinationals
With the setting up of a new Department of Pharmaceuticals, the Indian Pharmaceutical Alliance, a powerful lobby of the top 11 Indian generic drug makers, has upped its ante against brand-drug multinational companies
Indian Generic Group Tells New Department Of Pharmaceuticals That Industry Is Under Attack By Multinationals
With the setting up of a new Department of Pharmaceuticals, the Indian Pharmaceutical Alliance, a powerful lobby of the top 11 Indian generic drug makers, has upped its ante against brand-drug multinational companies
India’s Draft Pharma Policy Could Pass On April 30
NEW DELHI - The much-delayed draft pharmaceutical policy for India could be finalized by the end of the month, government sources told PharmAsia News.